NORDIX DNA ApS: Financial statements 2019
CVR: 36908130
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
NORDIX DNA ApS (CVR 36908130) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,000 and a net result of DKK -1,000 compared with DKK -2,000 the year before. Equity in the 2019 report amounted to DKK -7,015. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,000
- Profit/Loss
- DKK -1,000
- Equity
- DKK -7,015
- Total Assets
- DKK 22,175
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1 t. | -1 t. | -7 t. | 1 |
| 2018 | - | -2 t. | -2 t. | -6 t. | 1 |
| 2017 | - | 0 | 0 | -4 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NORDIX DNA ApS has published its annual report for 2018. Gross profit came to DKK -2,000, and the net result was DKK -2,000.
About NORDIX DNA ApS
NORDIX DNA ApS is a Danish company of the type Anpartsselskab based in Frederikshavn, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named NORDIX DNA IVS and FAB.DK IVS. The management consists of Casper Holm Mulberg. The company is owned by NORDIX HOLDING ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.